Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 宁波健信超导科技股份有限公司主要从事医用磁共振成像（MRI）设备核心部件的研发、生产和销售，主要产品包括超导磁体、永磁体和梯度线圈。 公司以“成为全球磁共振核心部件行业的领导品牌”为愿景，坚持以“设计并生产先进的MRI核心部件和推动磁共振行业发展”为己任，以“通过掌握核心技术并持续创新，让磁共振成为老百姓用得起的日常诊查手段，为大众健康和人类幸福不懈努力”为使命，掌握并突破MRI行业核心部件技术。 公司设有浙江省高新技术企业研究开发中心、浙江省博士后工作站、院士工作站，并于2023年入选国家专精特新“小巨人”企业，2024年入选国家专精特新重点“小巨人”企业。公司自成立以来获得多次殊荣，并先后承担、参与了多项重大科研项目，其中成功研制的“1.5T无液氦超导磁体系统”被认定为2021年度浙江省高端装备制造业重点领域国际首台（套）产品。 公司分别于2019年及2021年完成印度交付中心及意大利交付中心的落地，实现了由本土企业向国际化企业的升级转变，初步形成全球化产业布局。 未来公司将进一步拓展超导技术的应用范围，让超导技术更好地服务电力、交通等更广阔的工业领域，为超导技术的产业化做出更大贡献。
Main Business 从事医用磁共振成像（MRI）设备核心部件的研发、生产和销售。
Legal Representative 许建益
Top Executives
董事长：许建益
董事：许卉,郑杰,姚海锋,项超麟,赵吉明
独立董事：何丕模,贺超,寿碧英
Top 5 Shareholder
Shareholder name Nature Holding Date
许建益限售股31.13%23/12/2025
郑杰限售股7.26%23/12/2025
宁波韵升股份有限公司限售股6.54%23/12/2025
赵吉明限售股6.54%23/12/2025
宁波凯方投资合伙企业（有限合伙）限售股3.63%23/12/2025
Company Secretary 许卉
Solicitors 国浩律师（上海）事务所
Auditors 天健会计师事务所（特殊普通合伙）
Tel No 0574-63235707
Fax No 0574-63235707
Website www.healthcredit.cn
Email ir@healthcredit.cn
Company Address
Register: 浙江省慈溪高新技术产业开发区高科大道427号
Office: 浙江省慈溪高新技术产业开发区高科大道427号
Listing Date 24/12/2025
Shares Capital
Shares Capital: 167,680,000
Total A Share: 167,680,000
Listed A Share: 31,518,859
Non-tradable A Share: 136,161,141
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.440
DPS(RMB)* --
NBV Per Share(RMB)* ¥ 3.760
Market Capitalization(RMB) 0.000B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.